Stoptussin Phyto (Syrup) Instructions for Use
Marketing Authorization Holder
Teva Pharmaceutical Industries, Ltd. (Israel)
Manufactured By
Teva Czech Industries, s.r.o. (Czech Republic)
Contact Information
TEVA (Israel)
ATC Code
R05X (Other remedies for the treatment of colds)
Active Substances
Thymi herba (BP British Pharmacopoeia)
Thymus serpyllum (DAB German Pharmacopoeia)
Plantaginis lanceolatae herba (DAB German Pharmacopoeia)
Dosage Form
| Stoptussin Phyto | Syrup 4.1624 g+4.163 g+4.1666 g/100 g: 100 ml bottle with measuring cap included |
Dosage Form, Packaging, and Composition
Syrup in the form of a thick brown liquid with a characteristic odor.
| 100 g | |
| Thyme herb liquid ethanol extract (Thymi extractum fluidum ethanolum) | 4.1624 g |
| Wild thyme herb liquid ethanol extract (Serpylli extractum fluidum ethanolum) | 4.163 g |
| Ribwort plantain herb liquid ethanol extract (Plantaginis extractum fluidum ethanolum) | 4.1666 g |
Excipients: honey, sodium benzoate, sucrose, glycerol 85%, water.
100 ml – dark glass bottles (1) complete with a measuring cap – cardboard packs×.
× protective stickers may also be applied.
Clinical-Pharmacological Group
Herbal preparation with expectorant and anti-inflammatory effects
Pharmacotherapeutic Group
Herbal expectorant
Pharmacological Action
An expectorant preparation of herbal origin.
It has an expectorant and anti-inflammatory effect and helps to reduce the viscosity of sputum.
Pharmacokinetics
Data on the pharmacokinetics of Stoptussin Phyto are not provided.
Indications
As part of complex therapy for acute and chronic inflammatory diseases of the respiratory tract, accompanied by cough with difficult-to-discharge sputum
- Tracheitis;
- Bronchitis;
- Tracheobronchitis.
ICD codes
| ICD-10 code | Indication |
| J04 | Acute laryngitis and tracheitis |
| J20 | Acute bronchitis |
| J37 | Chronic laryngitis and laryngotracheitis |
| J42 | Unspecified chronic bronchitis |
| R05 | Cough |
| ICD-11 code | Indication |
| CA05 | Acute laryngitis or tracheitis |
| CA0G | Chronic laryngitis or laryngotracheitis |
| CA20.1Z | Chronic bronchitis, unspecified |
| CA42.Z | Acute bronchitis, unspecified |
| MD12 | Cough |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
The drug is administered orally, after meals (due to the possibility of decreased appetite).
Adults and children over 15 years old – 1 tablespoon 3-5 times/day.
Children aged from 1 year to 5 years – 1/2-1 teaspoon 2-3 times/day, from 5 to 10 years – 1-2 teaspoons 3 times/day, from 10 to 15 years – 2-3 teaspoons 3 times/day.
The average course of treatment is 7 days. Increasing the duration of treatment and conducting repeated courses is possible on the recommendation of a doctor.
Adverse Reactions
Possible allergic reactions.
Contraindications
- Cardiac decompensation;
- Liver diseases;
- Kidney diseases;
- Congenital fructose intolerance;
- Impaired absorption of glucose and galactose;
- Deficiency of the enzyme that breaks down sucrose and isomaltose;
- Pregnancy;
- Lactation period (breastfeeding);
- Children under 1 year of age;
- Hypersensitivity to the components of the drug.
With caution (due to the presence of ethanol in the preparation), the drug should be used in patients with alcoholism, epilepsy, brain diseases and injuries.
Use in Pregnancy and Lactation
The drug is contraindicated for use during pregnancy and lactation (breastfeeding).
Use in Hepatic Impairment
The drug is contraindicated in liver diseases.
Use in Renal Impairment
The drug is contraindicated in kidney diseases.
Pediatric Use
Contraindication: children under 1 year of age. The drug should be prescribed with caution to children (due to the possible negative effect of ethanol).
Special Precautions
The drug contains 3.4% vol. ethanol; 1 teaspoon (5 ml) contains up to 0.14 g of ethanol; 1 tablespoon (15 ml) – up to 0.41 g of ethanol.
The drug contains 62% sucrose, so it should be used with caution in patients with diabetes mellitus and in persons on a low-carbohydrate diet. 1 teaspoon of the drug contains up to 3.1 g of sucrose, 1 tablespoon – up to 9.3 g of sucrose.
Use in pediatrics
The drug should be prescribed with caution to children (due to the possible negative effect of ethanol).
Overdose
Data on overdose of Stoptussin Phyto are not provided.
Drug Interactions
Stoptussin Phyto should not be used simultaneously with drugs containing codeine and other antitussive drugs, as this makes it difficult to cough up liquefied sputum.
Storage Conditions
The drug should be stored out of the reach of children, in a light-protected place at a temperature from 10°C (50°F) to 25°C (77°F).
Shelf Life
Shelf life – 4 years.
Dispensing Status
The drug is available without a prescription.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Actovegin pills 200mg, 50pcs
Ingavirin capsules 90mg, 10pcs
Daivobet, ointment, 30g
Noopept, pills 10mg, 50pcs
OKI, sachets 80mg 2g, 12pcs
Fenotropil pills 100mg, 60pcs
Picamilon pills 50mg, 60pcs
Cortexin, 10mg, 5ml, 10pcs
Kagocel pills 12mg, 30pcs
Phenibut-Vertex pills 250mg, 20pcs
Belosalic, ointment, 30g
Cavinton Comfort, dispersible pills 10mg 90pcs
Arbidol, capsules 100mg, 40pcs
Nootropil pills 800mg, 30pcs
Belosalic, lotion solution for external use spray 100ml
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Mildronate capsules 500mg, 90pcs 